annual operating profit:
$2.25B+$25.00M(+1.12%)Summary
- As of today (May 29, 2025), TAK annual operating income is $2.25 billion, with the most recent change of +$25.00 million (+1.12%) on March 1, 2025.
- During the last 3 years, TAK annual operating profit has fallen by -$2.61 billion (-53.76%).
- TAK annual operating profit is now -53.76% below its all-time high of $4.86 billion, reached on March 31, 2022.
Performance
TAK Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$491.40M-$344.23M(-233.89%)Summary
- As of today (May 29, 2025), TAK quarterly operating income is -$491.40 million, with the most recent change of -$344.23 million (-233.89%) on March 1, 2025.
- Over the past year, TAK quarterly operating profit has dropped by -$1.14 billion (-175.33%).
- TAK quarterly operating profit is now -117.51% below its all-time high of $2.81 billion, reached on December 31, 2008.
Performance
TAK quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$2.27B-$1.14B(-33.50%)Summary
- As of today (May 29, 2025), TAK TTM operating income is $2.27 billion, with the most recent change of -$1.14 billion (-33.50%) on March 1, 2025.
- Over the past year, TAK TTM operating profit has increased by +$1.15 billion (+101.75%).
- TAK TTM operating profit is now -55.99% below its all-time high of $5.16 billion, reached on December 31, 2008.
Performance
TAK TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
TAK Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.1% | -175.3% | +101.8% |
| 3 y3 years | -53.8% | -168.3% | -53.7% |
| 5 y5 years | -14.8% | -143.1% | -13.9% |
TAK Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -53.8% | +1.1% | -126.7% | at low | -53.7% | +135.6% |
| 5 y | 5-year | -53.8% | +1.1% | -121.6% | at low | -55.3% | +135.6% |
| alltime | all time | -53.8% | +290.3% | -117.5% | +86.0% | -56.0% | +264.6% |
TAK Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $2.25B(+1.1%) | -$491.40M(+233.9%) | $2.27B(-33.5%) |
| Dec 2024 | - | -$147.17M(-108.0%) | $3.41B(+8.5%) |
| Sep 2024 | - | $1.84B(+72.7%) | $3.15B(+226.5%) |
| Jun 2024 | - | $1.07B(+63.6%) | $963.96M(-14.4%) |
| Mar 2024 | $2.22B(-45.9%) | $652.28M(-257.7%) | $1.13B(-31.0%) |
| Dec 2023 | - | -$413.69M(+21.1%) | $1.63B(-47.2%) |
| Sep 2023 | - | -$341.59M(-127.8%) | $3.09B(-26.2%) |
| Jun 2023 | - | $1.23B(+6.1%) | $4.19B(+1.6%) |
| Mar 2023 | $4.11B(-15.5%) | $1.16B(+11.1%) | $4.12B(+11.9%) |
| Dec 2022 | - | $1.04B(+37.9%) | $3.68B(+0.5%) |
| Sep 2022 | - | $756.01M(-34.9%) | $3.66B(-3.4%) |
| Jun 2022 | - | $1.16B(+61.5%) | $3.79B(-22.6%) |
| Mar 2022 | $4.86B(+23.5%) | $719.44M(-29.8%) | $4.90B(+3.5%) |
| Dec 2021 | - | $1.02B(+15.8%) | $4.74B(-6.8%) |
| Sep 2021 | - | $885.15M(-61.0%) | $5.08B(+9.2%) |
| Jun 2021 | - | $2.27B(+308.8%) | $4.65B(+18.2%) |
| Mar 2021 | $3.94B(+49.3%) | $555.42M(-59.5%) | $3.94B(-12.9%) |
| Dec 2020 | - | $1.37B(+201.1%) | $4.52B(+24.1%) |
| Sep 2020 | - | $455.13M(-70.7%) | $3.64B(-3.7%) |
| Jun 2020 | - | $1.55B(+36.3%) | $3.78B(+43.3%) |
| Mar 2020 | $2.64B(+52.1%) | $1.14B(+131.7%) | $2.64B(+298.7%) |
| Dec 2019 | - | $492.11M(-17.4%) | $661.81M(-43.3%) |
| Sep 2019 | - | $595.43M(+44.9%) | $1.17B(-4.9%) |
| Jun 2019 | - | $410.95M(-149.1%) | $1.23B(-28.8%) |
| Mar 2019 | $1.73B(+2.8%) | -$836.68M(-183.9%) | $1.72B(+31.4%) |
| Dec 2018 | - | $997.55M(+52.1%) | $1.31B(+20.0%) |
| Sep 2018 | - | $655.71M(-27.7%) | $1.09B(+38.0%) |
| Jun 2018 | - | $906.49M(-172.6%) | $791.67M(-51.7%) |
| Mar 2018 | $1.69B(+86.0%) | -$1.25B(-260.3%) | $1.64B(-10.8%) |
| Dec 2017 | - | $778.64M(+119.3%) | $1.84B(+17.3%) |
| Sep 2017 | - | $354.99M(-79.8%) | $1.57B(+20.4%) |
| Jun 2017 | - | $1.75B(-267.2%) | $1.30B(+35.2%) |
| Mar 2017 | $907.09M(-16.8%) | -$1.05B(-306.9%) | $963.07M(-43.2%) |
| Dec 2016 | - | $507.24M(+467.8%) | $1.69B(+2.3%) |
| Sep 2016 | - | $89.33M(-93.7%) | $1.66B(-19.8%) |
| Jun 2016 | - | $1.42B(-545.1%) | $2.07B(+95.2%) |
| Mar 2016 | $1.09B | -$318.10M(-167.8%) | $1.06B(-176.7%) |
| Dec 2015 | - | $469.49M(-5.8%) | -$1.38B(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $498.36M(+22.0%) | -$1.13B(+1.0%) |
| Jun 2015 | - | $408.54M(-114.8%) | -$1.12B(+23.8%) |
| Mar 2015 | -$1.18B(-185.0%) | -$2.76B(-482.6%) | -$901.85M(-160.5%) |
| Dec 2014 | - | $720.15M(+41.2%) | $1.49B(+3.8%) |
| Sep 2014 | - | $509.99M(-18.2%) | $1.43B(-1.6%) |
| Jun 2014 | - | $623.45M(-271.3%) | $1.46B(+3.1%) |
| Mar 2014 | $1.39B(+76.8%) | -$364.01M(-154.7%) | $1.41B(+66.9%) |
| Dec 2013 | - | $665.03M(+24.8%) | $847.19M(+20.9%) |
| Sep 2013 | - | $533.05M(-8.0%) | $700.59M(-6.9%) |
| Jun 2013 | - | $579.46M(-162.3%) | $752.66M(-21.1%) |
| Mar 2013 | $786.44M(-76.6%) | -$930.35M(-279.5%) | $953.73M(-49.4%) |
| Dec 2012 | - | $518.44M(-11.4%) | $1.88B(-8.7%) |
| Sep 2012 | - | $585.12M(-25.0%) | $2.06B(+52.3%) |
| Jun 2012 | - | $780.53M(>+9900.0%) | $1.36B(-58.7%) |
| Mar 2012 | $3.36B(-21.2%) | $101.00K(-100.0%) | $3.28B(-1474.8%) |
| Dec 2011 | - | $697.46M(-667.2%) | -$238.52M(-114.1%) |
| Sep 2011 | - | -$122.97M(-104.5%) | $1.69B(-61.3%) |
| Jun 2011 | - | $2.70B(-176.9%) | $4.37B(+7.9%) |
| Mar 2011 | $4.26B(-5.9%) | -$3.52B(-233.8%) | $4.05B(-8.8%) |
| Dec 2010 | - | $2.63B(+2.9%) | $4.44B(+3.0%) |
| Sep 2010 | - | $2.56B(+7.2%) | $4.31B(+0.6%) |
| Jun 2010 | - | $2.39B(-176.3%) | $4.29B(-2.4%) |
| Mar 2010 | $4.53B(+46.9%) | -$3.13B(-225.1%) | $4.40B(+1.2%) |
| Dec 2009 | - | $2.50B(-1.3%) | $4.34B(-6.6%) |
| Sep 2009 | - | $2.53B(+1.6%) | $4.65B(+4.0%) |
| Jun 2009 | - | $2.49B(-178.4%) | $4.47B(+125.9%) |
| Mar 2009 | $3.08B(-17.0%) | -$3.18B(-213.3%) | $1.98B(-61.6%) |
| Dec 2008 | - | $2.81B(+19.3%) | $5.16B(+119.3%) |
| Sep 2008 | - | $2.35B | $2.35B |
| Mar 2008 | $3.71B(-5.3%) | - | - |
| Mar 2007 | $3.92B(+10.1%) | - | - |
| Mar 2006 | $3.56B(-0.8%) | - | - |
| Mar 2005 | $3.59B(+8.9%) | - | - |
| Mar 2004 | $3.30B(+29.2%) | - | - |
| Mar 2003 | $2.55B(+13.3%) | - | - |
| Mar 2002 | $2.25B(+9.9%) | - | - |
| Mar 2001 | $2.05B(+32.5%) | - | - |
| Mar 2000 | $1.55B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual operating income?
- What is the all time high annual operating profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual operating profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly operating income?
- What is the all time high quarterly operating profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly operating profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM operating income?
- What is the all time high TTM operating profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM operating profit year-on-year change?
What is Takeda Pharmaceutical Company Limited annual operating income?
The current annual operating profit of TAK is $2.25B
What is the all time high annual operating profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual operating income is $4.86B
What is Takeda Pharmaceutical Company Limited annual operating profit year-on-year change?
Over the past year, TAK annual operating income has changed by +$25.00M (+1.12%)
What is Takeda Pharmaceutical Company Limited quarterly operating income?
The current quarterly operating profit of TAK is -$491.40M
What is the all time high quarterly operating profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly operating income is $2.81B
What is Takeda Pharmaceutical Company Limited quarterly operating profit year-on-year change?
Over the past year, TAK quarterly operating income has changed by -$1.14B (-175.33%)
What is Takeda Pharmaceutical Company Limited TTM operating income?
The current TTM operating profit of TAK is $2.27B
What is the all time high TTM operating profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM operating income is $5.16B
What is Takeda Pharmaceutical Company Limited TTM operating profit year-on-year change?
Over the past year, TAK TTM operating income has changed by +$1.15B (+101.75%)